Insulin glargine effectively achieves glycemic control and improves insulin resistance in patients with early type 2 diabetes that exhibit a high risk for cardiovascular disease

By            

Experimental and Therapeutic Medicine, Vol. 8, Iss. 1, 2014-01 ,pp. : 147-152

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of switching from premixed insulin to insulin glargine regimen in Type 2 diabetes mellitus patients with different islet functions

By                    

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 1096-1102

Spandidos Publications

Access to resources Recommend Favorite

Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia

By Cole Peter   Drachtman Richard   Masterson Margaret   Smith Angela   Glod John   Zebala John   Lisi Stacey   Drapala Drew-Anne   Kamen Barton  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 65-75

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes

By                

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1191-1196

Spandidos Publications

Access to resources Recommend Favorite

Effect of Exogenous Insulin and Glucagon on Exocrine Pancreatic Secretion in Rats In Vivo

By  

International Journal of Gastrointestinal Cancer, Vol. 28, Iss. 1, 2000-08 ,pp. : 67-76

Humana Press, Inc

Access to resources Recommend Favorite